BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6579938)

  • 21. Ten years of experience with amiodarone.
    Rosenbaum MB; Chiale PA; Haedo A; Lázzari JO; Elizari MV
    Am Heart J; 1983 Oct; 106(4 Pt 2):957-64. PubMed ID: 6613843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias.
    Kato K
    Ann N Y Acad Sci; 1992 Jan; 644():235-45. PubMed ID: 1562118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of amiodarone for refractory supraventricular tachyarrhythmias.
    Graboys TB; Podrid PJ; Lown B
    Am Heart J; 1983 Oct; 106(4 Pt 2):870-6. PubMed ID: 6613832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone treatment in patients with ventricular arrhythmias.
    Prystowsky EN; Heger JJ; Miles WM; Zipes DP
    Drugs; 1985 Mar; 29 Suppl 3():47-52. PubMed ID: 3996245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone: pharmacology and antiarrhythmic and adverse effects.
    Naccarelli GV; Rinkenberger RL; Dougherty AH; Giebel RA
    Pharmacotherapy; 1985; 5(6):298-313. PubMed ID: 2934688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
    Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
    Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up.
    Peter T; Hamer A; Mandel WJ; Weiss D
    Am Heart J; 1983 Oct; 106(4 Pt 2):943-50. PubMed ID: 6613841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Amiodarone, a class 3 antiarrhythmic agent: current electrophysiological and therapeutic aspects].
    Depelchin P; Schoenfeld P; Stoupel E; Degré S
    Rev Med Brux; 1986 Feb; 7(2):92-103. PubMed ID: 3515481
    [No Abstract]   [Full Text] [Related]  

  • 31. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
    Rotmensch HH; Belhassen B; Swanson BN; Shoshani D; Spielman SR; Greenspon AJ; Greenspan AM; Vlasses PH; Horowitz LN
    Ann Intern Med; 1984 Oct; 101(4):462-9. PubMed ID: 6476633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome.
    Brugada P; Wellens HJ
    Am J Cardiol; 1985 Nov; 56(13):863-6. PubMed ID: 4061328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R
    Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiarrhythmic effect and side effects of amiodarone].
    Weber H; Weissel M; Haddad R; Scheibelhofer W; Konrad K; Mlczoch J; Probst P; Mainitz M
    Wien Klin Wochenschr; 1984 Sep; 96(18):685-96. PubMed ID: 6523885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiodarone treatment of critical arrhythmias in children and young adults.
    Garson A; Gillette PC; McVey P; Hesslein PS; Porter CJ; Angell LK; Kaldis LC; Hittner HM
    J Am Coll Cardiol; 1984 Oct; 4(4):749-55. PubMed ID: 6384328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of amiodarone in resistant arrhythmias.
    Hollman A; Holt PM
    J R Soc Med; 1980 Dec; 73(12):842-4. PubMed ID: 7452643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long term follow-up.
    Peter T; Hamer A; Mandel WJ
    Eur Heart J; 1985 Nov; 6 Suppl D():151-62. PubMed ID: 4085515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amiodarone for tachyarrhythmias: pharmacology, kinetics, and efficacy.
    Canada AT; Lesko LJ; Haffajee CI; Johnson B; Asdourian GK
    Drug Intell Clin Pharm; 1983 Feb; 17(2):100-4. PubMed ID: 6337802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiodarone in the treatment of patients with refractory symptomatic ventricular and supraventricular arrhythmias. A long-term follow-up study.
    Lloyd EA; Mabin TA
    S Afr Med J; 1983 May; 63(20):759-63. PubMed ID: 6342169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse reactions during treatment with amiodarone hydrochloride.
    McGovern B; Garan H; Kelly E; Ruskin JN
    Br Med J (Clin Res Ed); 1983 Jul; 287(6386):175-80. PubMed ID: 6409240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.